We are live on ! Find out more
KCPG

Kavar Capital Partners Group Portfolio holdings

AUM $812M
1-Year Est. Return 29.76%
This Fund
S&P 500
This Quarter Est. Return
+0.52%
1 Year Est. Return
+29.76%
3 Year Est. Return
+77.21%
5 Year Est. Return
+92.54%
10 Year Est. Return
+280.51%
AUM
$439M
AUM Growth
+$24.5M
Cap. Flow
+$24.1M
Cap. Flow %
5.48%
Top 10 Hldgs %
32.49%
Holding
174
New
25
Increased
59
Reduced
48
Closed
2

Top Sells

Rank Stock Value
1
GDRX icon
GoodRx Holdings
GDRX
+$327K
2
AMGN icon
Amgen
AMGN
+$205K
3
AMLP icon
Alerian MLP ETF
AMLP
+$203K
4
T icon
AT&T
T
+$203K
5
NVDA icon
NVIDIA
NVDA
+$116K

Sector Composition

Rank Sector Weight
1 Healthcare 17.76%
2 Technology 12.73%
3 Financials 10.64%
4 Consumer Staples 10.37%
5 Communication Services 6.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STE icon
26
Steris
STE
$22.6B
$5.28M 1.2%
25,822
-160
-0.6% -$34.2K
EEFT icon
27
Euronet Worldwide
EEFT
$2.89B
$5.24M 1.19%
41,176
+1,004
+2% +$133K
V icon
28
Visa
V
$691B
$5.16M 1.17%
23,145
+440
+2% +$103K
ABT icon
29
Abbott
ABT
$183B
$5.1M 1.16%
43,185
-71
-0.2% -$8.72K
ABBV icon
30
AbbVie
ABBV
$432B
$5.02M 1.14%
46,523
+2,905
+7% +$332K
JPM icon
31
JPMorgan Chase
JPM
$956B
$4.95M 1.13%
30,242
+672
+2% +$105K
TFC icon
32
Truist Financial
TFC
$64.7B
$4.26M 0.97%
72,679
+1,033
+1% +$57.7K
IBM icon
33
IBM
IBM
$220B
$4.05M 0.92%
30,474
-28
-0.1% -$3.74K
SCHW
34
Charles Schwab
SCHW
$185B
$3.97M 0.91%
54,541
-1,190
-2% -$85K
MDLZ icon
35
Mondelez International
MDLZ
$79B
$3.52M 0.8%
60,471
-775
-1% -$48.2K
STZ icon
36
Constellation Brands
STZ
$22.4B
$3.4M 0.78%
16,156
+2,592
+19% +$566K
COST icon
37
Costco
COST
$420B
$3.27M 0.74%
7,276
+231
+3% +$102K
NVO
38
Novo Nordisk
NVO
$197B
$3.24M 0.74%
67,428
-500
-0.7% -$24.2K
AMZN icon
39
Amazon
AMZN
$2.99T
$3.18M 0.72%
19,360
+320
+2% +$55.2K
WMT icon
40
Walmart Inc
WMT
$884B
$3.14M 0.72%
67,551
+957
+1% +$46.1K
EMR icon
41
Emerson Electric
EMR
$87.7B
$3.12M 0.71%
33,076
+362
+1% +$36.1K
BAX icon
42
Baxter International
BAX
$14.4B
$3.1M 0.71%
38,562
-325
-0.8% -$25.7K
CTSH icon
43
Cognizant
CTSH
$25B
$3.03M 0.69%
40,829
+232
+0.6% +$17.1K
GM icon
44
General Motors
GM
$77.5B
$2.92M 0.67%
55,400
GS icon
45
Goldman Sachs
GS
$312B
$2.9M 0.66%
7,672
+160
+2% +$62.5K
EW icon
46
Edwards Lifesciences
EW
$51.4B
$2.87M 0.65%
25,355
+235
+0.9% +$26.8K
DGX icon
47
Quest Diagnostics
DGX
$25.8B
$2.84M 0.65%
19,575
-125
-0.6% -$18.3K
MCD icon
48
McDonald's
MCD
$189B
$2.81M 0.64%
11,671
HD icon
49
Home Depot
HD
$347B
$2.76M 0.63%
8,417
+325
+4% +$107K
ORLY icon
50
O'Reilly Automotive
ORLY
$74.8B
$2.75M 0.63%
67,545
+5,775
+9% +$231K

Similar funds

Kavar Capital Partners Group's Q3 2021 Portfolio in Review

As of Q3 2021, Kavar Capital Partners Group held 174 positions worth $439M, up 5.9% from $414M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Kavar Capital Partners Group deployed $24.1M of net new capital in Q3 2021, opening 25 new positions and adding to 59 existing holdings. Its largest new stake was American Electric Power Company, Inc. Corporate Units: 17,100 shares worth $850K.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 18% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was GoodRx Holdings, an estimated $327K trimmed.

  • Kavar Capital Partners Group's largest Q3 2021 buy was American Electric Power Company, Inc. Corporate Units: 17,100 shares worth $850K.
  • Kavar Capital Partners Group added most to Schwab Fundamental US Large Company Index ETF in Q3 2021, an estimated $5.62M increase.
  • Kavar Capital Partners Group's biggest Q3 2021 reduction was GoodRx Holdings, cutting an estimated $327K.
  • Kavar Capital Partners Group fully exited Amgen in Q3 2021, selling an estimated $205K.
  • Kavar Capital Partners Group's ten largest holdings make up 32% of its $439M portfolio in Q3 2021.
  • Kavar Capital Partners Group opened 25 new positions and closed 2 in Q3 2021.
  • Kavar Capital Partners Group's portfolio value rose 5.9% quarter-over-quarter to $439M.

Based on Kavar Capital Partners Group's 13F filing for Q3 2021, filed 1 Nov 2021.